Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131

Karen L. Smith, Fengmin Zhao, Ingrid A. Mayer, Amye J. Tevaarwerk, Sofia F. Garcia, Carlos L. Arteaga, William F. Symmans, Ben H. Park, Brian L. Burnette, Della F. Makower, Margaret Block, Kimberly A. Morley, Chirag R. Jani, Craig Mescher, Shabana J. Dewani, Ursa Brown-Glaberman, Lisa E. Flaum, Erica L. Mayer, William M. Sikov, Eve T. RodlerAngela M. DeMichele, Joseph A. Sparano, Antonio C. Wolff, Kathy D. Miller, Lynne I. Wagner

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131'. Together they form a unique fingerprint.

Medicine & Life Sciences